Testing effectiveness (Phase 2)Ended earlyNCT01228266What this trial is testingMesenchymal Stem Cell Transplantation in MSWho this might be right forMultiple Sclerosis Albert Saiz 9
Testing effectiveness (Phase 2)Ended earlyNCT03183869What this trial is testingFecal Microbial Transplantation in Relapsing Multiple Sclerosis PatientsWho this might be right forAutoimmune DiseasesRelapsing Multiple Sclerosis London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 14
Not applicableStudy completedNCT04844489What this trial is testingStudy of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised PeopleWho this might be right forAutoimmune or Autoinflammatory DiseasesHIVMultiple Sclerosis+2 more Assistance Publique - Hôpitaux de Paris 377
Early research (Phase 1)Study completedNCT00014755What this trial is testingPhase I Pilot Study of Total-Body Irradiation, Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple SclerosisWho this might be right forMultiple Sclerosis Fred Hutchinson Cancer Center 35
Testing effectiveness (Phase 2)Study completedNCT00342134What this trial is testingImmunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple SclerosisWho this might be right forMultiple Sclerosis National Institute of Neurological Disorders and Stroke (NINDS) 34
Not applicableLooking for participantsNCT07635693What this trial is testingATLG Levels in Autologous HSCT for Multiple SclerosisWho this might be right forMultiple SclerosisAutologous Hematopoietic Stem Cell TransplantATLG Ciceri Fabio 20
Testing effectiveness (Phase 2)WithdrawnNCT05098145What this trial is testingA Safety and Efficacy Study of FCR001 in Adults With Rapidly Progressive Diffuse Cutaneous Systemic SclerosisWho this might be right forDiffuse Cutaneous Systemic Sclerosis Talaris Therapeutics Inc.
Not applicableLooking for participantsNCT06567197What this trial is testingMultiple Sclerosis Treatment With Autologous Hematopoietic Stem Cell Transplantation in the NetherlandsWho this might be right forMultiple Sclerosis, Relapsing-Remitting Amsterdam UMC, location VUmc 24
Early research (Phase 1)Looking for participantsNCT05832515What this trial is testingAHSCT With Fludarabine and Cyclophosphamide Based Conditioning Regimes in Patients With Multiple SclerosisWho this might be right forMultiple Sclerosis St. Petersburg State Pavlov Medical University 200
Not applicableWithdrawnNCT05482542What this trial is testingOptimal Conditioning Regimen for Autologous Transplantation of Relapsing Remitting Multiple SclerosisWho this might be right forMultiple Sclerosis, Relapsing-Remitting Scripps Health
Large-scale testing (Phase 3)Active Not RecruitingNCT03477500What this trial is testingRandomized Autologous heMatopoietic Stem Cell Transplantation Versus Alemtuzumab, Cladribine or Ocrelizumab for RRMS (RAM-MS)Who this might be right forMultiple Sclerosis Haukeland University Hospital 100
Not applicableLooking for participantsNCT06195800What this trial is testingBiomarkers of aHSCTWho this might be right forMultiple Sclerosis, Relapsing-Remitting Sheffield Teaching Hospitals NHS Foundation Trust 15
Not applicableStudy completedNCT02601131What this trial is testingPost-transfusion Platelet CountWho this might be right forLeukemiaMultiple Sclerosis Region Skane 80
Testing effectiveness (Phase 2)WithdrawnNCT00497952What this trial is testingAllogeneic Stem Cell Transplantation for the Treatment of Multiple SclerosisWho this might be right forMultiple Sclerosis Talaris Therapeutics Inc.
Testing effectiveness (Phase 2)Study completedNCT01099930What this trial is testingAutologous Stem Cell Transplant for Multiple SclerosisWho this might be right forMultiple Sclerosis Ottawa Hospital Research Institute 24
Large-scale testing (Phase 3)Looking for participantsNCT04047628What this trial is testingBest Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)Who this might be right forRelapsing Multiple SclerosisRelapsing Remitting Multiple SclerosisSecondary Progressive Multiple Sclerosis National Institute of Allergy and Infectious Diseases (NIAID) 156
Post-approval studies (Phase 4)Study completedNCT04952766What this trial is testingStudy Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy AdultsWho this might be right forKidney TransplantMyelomaCancer+6 more Centre Hospitalier Régional d'Orléans 196
Testing effectiveness (Phase 2)Ended earlyNCT04971005What this trial is testingOcrelizumab or Alemtuzumab Compared With Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis - a Phase-2 Randomised Controlled TrialWho this might be right forRelapsing-Remitting Multiple Sclerosis Universitätsklinikum Hamburg-Eppendorf 1
Testing effectiveness (Phase 2)Study completedNCT00040482What this trial is testingHigh Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple SclerosisWho this might be right forMultiple Sclerosis Baylor College of Medicine 10
Not applicableNot Yet RecruitingNCT06228781What this trial is testingAutologous Hematopoietic Stem Cell Transplantation for Refractory Multiple SclerosisWho this might be right forMultiple Sclerosis Tianjin Medical University General Hospital 20